Etravirine

CAS No. 269055-15-4

Etravirine ( R-165335;TMC-125 )

Catalog No. M13823 CAS No. 269055-15-4

A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 38 In Stock
5MG 61 In Stock
10MG 102 In Stock
25MG 178 In Stock
50MG 264 In Stock
100MG 363 In Stock
200MG 460 In Stock
500MG 746 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Etravirine
  • Note
    Research use only, not for human use.
  • Brief Description
    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.
  • Description
    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.HIV Infection Approved
  • Synonyms
    R-165335;TMC-125
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    ReverseTranscriptase
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    269055-15-4
  • Formula Weight
    435.28
  • Molecular Formula
    C20H15BrN6O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    N#CC1=CC(C)=C(OC2=NC(NC3=CC=C(C#N)C=C3)=NC(N)=C2Br)C(C)=C1
  • Chemical Name
    Benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Das K, et al. J Med Chem, 2004, 47(10), 2550-2560.
2. Andries K, et al. Antimicrob Agents Chemother. 2004 Dec;48(12):4680-6.
3. Sankatsing SU, et al. AIDS. 2003 Dec 5;17(18):2623-7.
molnova catalog
related products
  • Cys-TAT(47-57)

    Cys-TAT(47-57) (Cys-[HIV-Tat (47-57)]) is an arginine rich cell penetrating peptide derived from the HIV-1 transactivating protein.This peptide corresponds to the protein transduction domain of the TAT protein.

  • Delavirdine mesylate

    A potent HIV-1 reverse transcriptase inhibitor with IC50 of 0.26 uM for recombinant HIV-1 RT.

  • HIV-1 inhibitor 18A

    HIV-1 inhibitor 18A is a novel broad HIV-1 inhibitor that blocks envelope glycoprotein transitions critical for entry.